Ocular Therapeutix, Inc. (OCUL)
10.76
+0.18
(+1.75%)
USD |
NASDAQ |
Sep 02, 13:14
Ocular Therapeutix Cash from Operations (Annual) : -204.88M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -204.88M |
| December 31, 2024 | -134.68M |
| December 31, 2023 | -70.23M |
| December 31, 2022 | -59.60M |
| December 31, 2021 | -65.55M |
| December 31, 2020 | -53.55M |
| December 31, 2019 | -77.58M |
| Date | Value |
|---|---|
| December 31, 2018 | -49.23M |
| December 31, 2017 | -50.47M |
| December 31, 2016 | -34.00M |
| December 31, 2015 | -33.74M |
| December 31, 2014 | -20.50M |
| December 31, 2013 | -12.64M |
| December 31, 2012 | -12.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| EyePoint, Inc. | -240.11M |
| LENZ Therapeutics, Inc. | -69.17M |
| Merck & Co., Inc. | 16.47B |
| Theravance Biopharma, Inc. | 238.54M |
| ANI Pharmaceuticals, Inc. | 185.22M |